MENU
RNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Avidity Biosciences (RNA) Earnings Date & Reports

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs... Show more

A.I. Advisor
published Earnings

RNA is expected to report earnings to fall 4.72% to -121 cents per share on March 03

Avidity Biosciences RNA Stock Earnings Reports
Q4'25
Est.
$-1.21
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.25
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.80
The last earnings report on November 10 showed earnings per share of -126 cents, missing the estimate of -113 cents. With 1.23M shares outstanding, the current market capitalization sits at 10.67B.
View a ticker or compare two or three
RNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNA showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in the research and development of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
10578 Science Center Drive
Phone
+1 858 401-7900
Employees
253
Web
https://www.aviditybiosciences.com